Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Alternatives to intensive treatment in patients with AML
Gracie Himmelstein
,
John Mascarenhas
,
Bridget K. Marcellino
Cancer Clinical Investigation
Graduate School of Biomedical Sciences
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - Hematology and Medical Oncology
Mount Sinai Tisch Cancer Center
Institute for Translational Medicine and Pharmacology
Research output
:
Contribution to journal
›
Review article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Alternatives to intensive treatment in patients with AML'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Myeloid Leukemia
100%
Advanced Age
25%
Chemotherapy Regimen
25%
Conventional Chemotherapy
25%
Genetic Properties
25%
Induction Chemotherapy
50%
Intensive Care Medicine
100%
Medical Comorbidity
25%
Molecular Properties
25%
New Agents
25%
New Treatment Options
50%
Ongoing Trials
25%
Poor Performance Status
25%
Recent Advances
25%
Serine Protease Autotransporters of Enterobacteriaceae (SPATEs)
25%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Chemotherapy
25%
Induction Chemotherapy
50%
Medical Comorbidities
25%
Molecular Property
25%
Treatment Option
50%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Chemotherapy
75%
Comorbidity
25%
Nursing and Health Professions
Acute Myeloid Leukemia
100%
Comorbidity
25%
Induction Chemotherapy
50%